High prevalence of iron deficiency in patients with acute decompensated heart failure

European Journal of Heart Failure

Volumn 16, Issue 9, 2014, Pages 984-991

  Cohen Solal, Alain ^a   Damy, Thibaud ^b   Terbah, Mohamed ^c   Kerebel, Sébastien ^d   Baguet, Jean Philippe ^e   Hanon, Olivier ^f   Zannad, Faiez ^g   Laperche, Thierry ^h   Leclercq, Christophe ⁱ   Concas, Victor ^j   Duvillié, Ladan ^j   Darné, Bernadette ^k   Anker, Stefan ^l   Mebazaa, Alexandre ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c Regional Hospital   (France)

^d Sainte Anne's Military Hospital   (France)

^e GRENOBLE UNIVERSITY HOSPITAL   (France)

^f Paris Descartes University   (France)

^g CHU NANCY BRABOIS   (France)

^h North Cardiologic Center   (France)

ⁱ PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^j Produits Roche   (France)

^k Monitoring Force Group   (France)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Acute decompensated heart failure; Anaemia; Chronic heart failure; Iron deficiency

Indexed keywords

ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; IRON;

ACUTE HEART FAILURE; AGED; ANEMIA; ARTICLE; CARDIOLOGY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PRACTICE GUIDELINE; PREVALENCE; SEX DIFFERENCE; VERY ELDERLY; ACUTE DISEASE; ANEMIA, IRON-DEFICIENCY; BLOOD; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; FRANCE; METABOLISM; MULTICENTER STUDY; PROGNOSIS; PROSPECTIVE STUDY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; FRANCE; HEART FAILURE; HUMANS; IRON; MALE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84908246200     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.139     Document Type: Article

References (41)

1. Krum H, Teerlink JR. Medical therapy for chronic heart failure. Lancet 2011;378:713-721.
2. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-2018.
3. Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008;52:501-511.
4. de Silva R, Rigby AS, Witte KK, Nikitin NP, Tin L, Goode K, Bhandari S, Clark AL, Cleland JG. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. Am J Cardiol 2006;98:391-398.
5. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P. Iron deficiency: An ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010;31:1872-1880.
6. Kalra PR, Bolger AP, Francis DP, Genth-Zotz S, Sharma R, Ponikowski PP, Poole-Wilson PA, Coats AJ, Anker SD. Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol 2003;91:888-891.
7. Klip IT, Comin-Colet J, Voors AA, Ponikowski P, Enjuanes C, BanasiakW, Lok DJ, Rosentryt P, Torrens A, Polonski L, van Veldhuisen DJ, van der Meer P, Jankowska EA. Iron deficiency in chronic heart failure: An international pooled analysis. Am Heart J 2013;165:575-582 e573.
8. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI. Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 2006;48:2485-2489.
9. Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol 2011;58:1241-1251.
10. Opasich C, Cazzola M, Scelsi L, De Feo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucili A, Moratti R, Tramarin R, Tavazzi L. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 2005;26:2232-2237.
11. Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL. Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J 2004;147:924-930.
12. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart RB, Pocock SJ, Poole-Wilson PA, Ponikowski P. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-2448.
13. Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R, Chapman CM. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. J Am Coll Cardiol 2006;48:1225-1227.
14. Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: A randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008;51:103-112.
15. Toblli JE, Lombrana A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007;50:1657-1665.
16. Usmanov RI, Zueva EB, Silverberg DS, Shaked M. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J Nephrol 2008;21:236-242.
17. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869.
18. Alexandrakis MG, Tsirakis G. Anemia in heart failure patients. ISRN Hematol 2012;2012:246915.
19. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 2009;1790:682-693.
20. World Health Organization/United Nations University/UNICEF. Iron Deficiency Anaemia, Assessment, Prevention and Control: A Guide for Programme Managers. Geneva: WHO; 2001.
21. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Mori C, von Eisenhart RB, Pocock S, Poole-Wilson PA, Ponikowski P. Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: A randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. Eur J Heart Fail 2009;11:1084-1091.
22. Silverberg DS, Schwartz D, Schwartz I, Ben AE. The missed opportunities to diagnose and treat iron deficiency in patients hospitalized with heart failure. Int J Cardiol 2013;168:2164-2166.
23. Étude nationale nutrition santé (ENNS, 2006). Situation nutritionnelle en France en 2006 selon les indicateurs d'objectif et les repères du Programme national nutrition santé (PNNS). Institut de veille sanitaire, Université de Paris 13, Conservatoire national des arts et métiers, 2007. http://www.invs.sante.fr/publications/2007/nutrition-enns/RAPP-INST-ENNS-Web.pdf.
24. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K, Mancini DM. Hemodilution is common in patients with advanced heart failure. Circulation 2003;107:226-229.
25. Cheung CL, Cheung TT, Lam KS, Cheung BM. High ferritin and low transferrin saturation are associated with pre-diabetes among a national representative sample of U.S. adults. Clin Nutr 2013;32:1055-1060.
26. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, Bingham S, Khaw KT, Wareham NJ. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007;50:949-956.
27. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004;27:2422-2428.
28. Auerbach M, Coyne D, Ballard H. Intravenous iron: From anathema to standard of care. Am J Hematol 2008;83:580-588.
29. Naito Y, Tsujino T, Fujimori Y, Sawada H, Akahori H, Hirotani S, Ohyanagi M, Masuyama T. Impaired expression of duodenal iron transporters in Dahl salt-sensitive heart failure rats. J Hypertens 2011;29:741-748.
30. Sandek A, Bauditz J, Swidsinski A, Buhner S, Weber-Eibel J, von Haehling S, Schroedl W, Karhausen T, Doehner W, Rauchhaus M, Poole-Wilson P, Volk HD, Lochs H, Anker SD. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol 2007;50:1561-1569.
31. de Groote P, Herpin D, Dievart F, Hanon O, Trochu JN, Artigou JY, Galinier M, Habib G, Juilliere Y, Neuder Y, Roudaut R, Komajda M. Treatment of heart failure with preserved systolic function. Arch Cardiovasc Dis 2008;101: 361-372.
32. Finch CA, Miller LR, Inamdar AR, Person R, Seiler K, Mackler B. Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. J Clin Invest 1976;58:447-453.
33. Willis WT, Gohil K, Brooks GA, Dallman PR. Iron deficiency: Improved exercise performance within 15 hours of iron treatment in rats. J Nutr 1990;120:909-916.
34. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-1995.
35. Brownlie T, Utermohlen V, Hinton PS, Haas JD. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 2004;79:437-443.
36. Cairo G, Bernuzzi F, Recalcati S. A precious metal: Iron, an essential nutrient for all cells. Genes Nutr 2006;1:25-39.
37. Comin-Colet J, Enjuanes C, Gonzalez G, Torrens A, Cladellas M, Merono O, Ribas N, Ruiz S, Gomez M, Verdu JM, Bruguera J. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status. Eur J Heart Fail 2013;15:1164-1172.
38. Comin-Colet J, Lainscak M, Dickstein K, Filippatos GS, Johnson P, Luscher TF, Mori C, Willenheimer R, Ponikowski P, Anker SD. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: A subanalysis of the FAIR-HF study. Eur Heart J 2013;34:30-38.
39. Gaber R, Kotb NA, Ghazy M, Nagy HM, Salama M, Elhendy A. Tissue Doppler and strain rate imaging detect improvement of myocardial function in iron deficient patients with congestive heart failure after iron replacement therapy. Echocardiography 2012;29:13-18.
40. Haas JD, Brownlie TT. Iron deficiency and reduced work capacity: A critical review of the research to determine a causal relationship. J Nutr 2001;131: 676S-688S.
41. Maeder MT, Khammy O, dos Remedios C, Kaye DM. Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol 2011;58:474-480.